百日咳:常见问题与解答
本文以问答形式综述百日咳的临床表现、诊断、免疫策略与抗生素使用。临床疑似时应以聚合酶链反应(PCR)确认;11岁及以上者至少接种一剂Tdap,孕妇每次妊娠27至36周接种Tdap;抗生素用于阻断传播而非缩短病程,阿奇霉素为首选。
要点
- 临床疑似百日咳应以PCR确认,已取代培养成为首选确认试验。
- 11岁及以上者至少接种一剂Tdap,可以替代任何剂次Td。
- 孕妇每次妊娠27至36周接种Tdap以传递新生儿免疫。
核心结论
- 百日咳仍是公共卫生问题,尽管过去三十年扩大了免疫推荐。
- 近期证据确认免疫或感染后获得性免疫减弱,导致Tdap免疫推荐发生变化。
- 抗生素治疗旨在防止传播,不缩短病程或改善症状。
研究设计与样本
- 本文为综述,检索范围未报告。
主要发现
- 百日咳表现随病程变化:卡他期症状非特异,阵发期咳嗽伴典型whooping,恢复期持续咳嗽。
- 临床疑似百日咳时应使用PCR确认诊断,已取代培养成为首选确认试验。
- 免疫或感染后获得性免疫减弱已被近期证据确认,导致Tdap推荐改变。
- 抗生素治疗旨在防止传播,不缩短病程或改善症状。
关键数值与推荐
- 11岁及以上患者应至少接种一剂Tdap,Tdap可替代任何剂次Td疫苗。
- 所有孕妇每次妊娠应在27至36周接种Tdap,以传递新生儿免疫。
- 不再推荐cocooning(为高风险个体密切接触者接种),因为已免疫者仍可感染和传播百日咳。
- 既往百日咳疫苗接种后癫痫或低张力低反应发作史不再为免疫禁忌。
- 推荐对百日咳患者的家庭接触者及暴露于百日咳且重症高风险者(如婴儿、免疫受损者或妊娠晚期)或与高风险者密切接触者进行抗生素预防。
临床怎么用
- 临床疑似百日咳时使用PCR确认诊断。
- 按推荐为11岁及以上者接种Tdap,并可替代任何剂次Td。
- 每次妊娠27至36周为孕妇接种Tdap。
- 对家庭接触者及重症高风险暴露者提供抗生素预防,首选阿奇霉素。
局限性
- 原文未报告综述检索范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pertussis, also known as whooping cough, remains a public health concern despite expanded immunization recommendations over the past three decades. The presentation of pertussis, which is variable and evolves over the course of the disease, includes nonspecific symptoms in the catarrhal stage, coughing with the classic whooping in the paroxysmal stage, and persistent cough in the convalescent stage. When there is clinical suspicion for pertussis, the diagnosis should be confirmed using polymerase chain reaction testing, which has replaced culture as the preferred confirmatory test. Recent evidence has confirmed a waning of acquired immunity following pertussis immunization or infection, leading to changes in tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) immunization recommendations. Patients 11 years or older should receive at least one dose of Tdap, although Tdap may replace any dose of the tetanus and diphtheria toxoids (Td) vaccine. All pregnant patients should receive Tdap between 27 and 36 weeks' gestation with each pregnancy to convey immunity to the newborn. Cocooning (vaccinating close contacts of high-risk individuals) is no longer recommended because immunized patients can still contract and transmit pertussis. A history of seizure or hypotonic-hyporesponsive episodes after a prior pertussis vaccination is no longer a contraindication to immunization. Antibiotic treatment is intended to prevent transmission of pertussis to others and does not shorten the disease course or improve symptoms. Antibiotic prophylaxis is recommended for household contacts of someone with pertussis and for those exposed to pertussis who are at high risk of severe illness (e.g., infants, people who are immunocompromised or in the third trimester of pregnancy) or in close contact with someone at high risk. Azithromycin is the preferred antibiotic for treatment or prophylaxis.
引用
- Kline JM, Smith EA, Zavala A, et al. Pertussis: Common Questions and Answers. Am Fam Physician. 2021. PMID: 34383446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。